Share Price and Basic Stock Data
Last Updated: December 5, 2025, 6:31 pm
| PEG Ratio | 6.71 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Kokuyo Camlin Ltd, a key player in the printing, publishing, and stationery industry, has seen notable fluctuations in its revenue over recent quarters. For instance, the company reported sales of ₹775 Cr in FY 2023, which rose to ₹816 Cr in FY 2024, indicating a year-on-year growth trajectory. However, the trailing twelve months (TTM) sales stand at ₹760 Cr, reflecting some volatility in recent performance. The quarterly sales figures reveal a mixed picture: while there was a strong uptick to ₹236 Cr in June 2023, the subsequent quarter saw a drop to ₹195 Cr. This inconsistency may raise questions about demand stability and market positioning. Furthermore, the company’s operating profit margin (OPM) has varied, peaking at 12% in June 2024 before dipping to a concerning -4% in September 2024. Such fluctuations signal potential operational challenges that could affect investor sentiment.
Profitability and Efficiency Metrics
When examining Kokuyo Camlin’s profitability, the company reported a net profit of ₹24 Cr in FY 2023, which subsequently increased to ₹44 Cr in FY 2024. However, the TTM net profit shows a decline to merely ₹6 Cr, raising concerns about ongoing profitability. The return on equity (ROE) is notably low at 1.95%, suggesting that the firm is not generating significant returns relative to shareholders’ equity. Efficiency metrics also present a mixed bag; for instance, the cash conversion cycle (CCC) stands at 109 days, which is relatively high, indicating that the company may take longer to convert its investments in inventory and receivables into cash. This could be a potential risk for liquidity. On the positive side, the interest coverage ratio (ICR) is a healthy 4.53x, suggesting that Kokuyo Camlin can comfortably meet its interest obligations, providing some cushion against financial distress.
Balance Sheet Strength and Financial Ratios
Kokuyo Camlin’s balance sheet exhibits a blend of strengths and weaknesses. The company holds reserves of ₹312 Cr, which provides a solid buffer against volatility; however, it also has borrowings of ₹12 Cr, suggesting a low leverage position. The price-to-book value (P/BV) ratio stands at 3.89x, which, while not excessive, indicates that the stock might be trading at a premium relative to its book value. The return on capital employed (ROCE) is at 3.65%, which appears stretched compared to industry benchmarks, indicating that the company may not be utilizing its capital as effectively as its peers. Additionally, with a current ratio of 1.32x, Kokuyo Camlin looks comfortable in terms of liquidity. However, the declining trend in net profit margins, which are now at 4% for FY 2025, raises concerns about the sustainability of profitability moving forward.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Kokuyo Camlin reveals a strong promoter commitment, with promoters holding a consistent 74.99% stake. This level of ownership can instill confidence among investors, as it suggests that the management has a vested interest in the company’s success. However, foreign institutional investors (FIIs) own just 0.09%, while domestic institutional investors (DIIs) have no stake in the company, which could reflect a lack of institutional interest or confidence in the stock. The public shareholding stands at 24.92%, with a total of 32,955 shareholders as of the latest report. The absence of institutional backing may pose challenges in terms of stock liquidity and could hinder broader market acceptance. This scenario can lead to higher volatility in share prices, which is something retail investors should consider when evaluating their investment strategy.
Outlook, Risks, and Final Insight
Looking ahead, Kokuyo Camlin faces a mix of opportunities and challenges. The company’s strong brand presence in the stationery market could support future growth, especially as educational and office supplies see steady demand. However, the volatility in revenue and profitability metrics, alongside a high cash conversion cycle, suggests that operational efficiency must be prioritized to enhance financial health. Risks include potential market saturation and increased competition, which could pressure margins further. Investors should also be wary of the low institutional interest, as it can signal broader market skepticism. Ultimately, while Kokuyo Camlin has several strengths, including strong promoter backing and manageable debt levels, the company must navigate its current challenges effectively to regain investor confidence and drive sustainable growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Kokuyo Camlin Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| H T Media Ltd | 539 Cr. | 23.2 | 28.6/14.5 | 25.1 | 71.0 | 0.00 % | 2.51 % | 0.03 % | 2.00 |
| Gala Global Products Ltd | 12.0 Cr. | 2.19 | 4.25/2.16 | 6.54 | 0.00 % | 2.28 % | 13.0 % | 5.00 | |
| Flair Writing Industries Ltd | 3,029 Cr. | 287 | 357/194 | 25.6 | 100.0 | 0.35 % | 15.6 % | 11.9 % | 5.00 |
| Doms Industries Ltd | 15,782 Cr. | 2,600 | 3,115/2,092 | 73.5 | 181 | 0.12 % | 26.2 % | 22.3 % | 10.0 |
| DB Corp Ltd | 4,527 Cr. | 254 | 344/189 | 13.1 | 129 | 4.72 % | 21.1 % | 16.7 % | 10.0 |
| Industry Average | 2,539.63 Cr | 414.52 | 85.18 | 207.90 | 1.09% | 9.42% | 9.72% | 6.27 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 196 | 190 | 173 | 216 | 236 | 195 | 168 | 217 | 229 | 173 | 161 | 200 | 227 |
| Expenses | 183 | 175 | 164 | 199 | 212 | 178 | 156 | 195 | 202 | 180 | 160 | 187 | 208 |
| Operating Profit | 14 | 15 | 9 | 17 | 24 | 17 | 13 | 23 | 28 | -8 | 0 | 13 | 20 |
| OPM % | 7% | 8% | 5% | 8% | 10% | 9% | 7% | 10% | 12% | -4% | 0% | 7% | 9% |
| Other Income | 0 | 0 | 2 | 0 | 5 | 0 | 0 | 0 | 1 | -0 | 0 | -0 | 0 |
| Interest | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Profit before tax | 8 | 10 | 6 | 12 | 24 | 13 | 7 | 16 | 22 | -14 | -6 | 7 | 14 |
| Tax % | 0% | 60% | 36% | 25% | 23% | 25% | 24% | 34% | 25% | -24% | -26% | 35% | 26% |
| Net Profit | 8 | 4 | 4 | 9 | 18 | 9 | 6 | 10 | 16 | -11 | -4 | 4 | 10 |
| EPS in Rs | 0.83 | 0.38 | 0.35 | 0.87 | 1.83 | 0.95 | 0.56 | 1.04 | 1.62 | -1.06 | -0.41 | 0.44 | 1.00 |
Last Updated: August 20, 2025, 8:00 am
Below is a detailed analysis of the quarterly data for Kokuyo Camlin Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 227.00 Cr.. The value appears strong and on an upward trend. It has increased from 200.00 Cr. (Mar 2025) to 227.00 Cr., marking an increase of 27.00 Cr..
- For Expenses, as of Jun 2025, the value is 208.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 187.00 Cr. (Mar 2025) to 208.00 Cr., marking an increase of 21.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 7.00 Cr..
- For OPM %, as of Jun 2025, the value is 9.00%. The value appears strong and on an upward trend. It has increased from 7.00% (Mar 2025) to 9.00%, marking an increase of 2.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 7.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 35.00% (Mar 2025) to 26.00%, marking a decrease of 9.00%.
- For Net Profit, as of Jun 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 6.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.00. The value appears strong and on an upward trend. It has increased from 0.44 (Mar 2025) to 1.00, marking an increase of 0.56.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:59 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 468 | 544 | 614 | 630 | 630 | 689 | 634 | 403 | 508 | 775 | 816 | 763 | 760 |
| Expenses | 465 | 527 | 590 | 606 | 591 | 637 | 597 | 394 | 492 | 721 | 739 | 729 | 735 |
| Operating Profit | 3 | 17 | 25 | 24 | 39 | 51 | 37 | 9 | 17 | 54 | 77 | 34 | 26 |
| OPM % | 1% | 3% | 4% | 4% | 6% | 7% | 6% | 2% | 3% | 7% | 9% | 4% | 3% |
| Other Income | 1 | 8 | 5 | 3 | 2 | 1 | 1 | 0 | 0 | 2 | 6 | 1 | 0 |
| Interest | 9 | 10 | 11 | 12 | 10 | 12 | 10 | 9 | 4 | 4 | 4 | 5 | 4 |
| Depreciation | 9 | 11 | 12 | 12 | 17 | 18 | 19 | 18 | 18 | 17 | 19 | 21 | 21 |
| Profit before tax | -13 | 4 | 7 | 2 | 15 | 23 | 9 | -18 | -5 | 35 | 59 | 9 | 1 |
| Tax % | -12% | -15% | 28% | 33% | 34% | 33% | 50% | -20% | 0% | 30% | 26% | 33% | |
| Net Profit | -12 | 5 | 5 | 2 | 10 | 15 | 4 | -15 | -5 | 24 | 44 | 6 | -0 |
| EPS in Rs | -1.15 | 0.49 | 0.52 | 0.15 | 0.98 | 1.52 | 0.43 | -1.46 | -0.47 | 2.44 | 4.37 | 0.58 | -0.03 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 21% | 11% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 141.67% | 0.00% | -60.00% | 400.00% | 50.00% | -73.33% | -475.00% | 66.67% | 580.00% | 83.33% | -86.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | -141.67% | -60.00% | 460.00% | -350.00% | -123.33% | -401.67% | 541.67% | 513.33% | -496.67% | -169.70% |
Kokuyo Camlin Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 4% |
| 3 Years: | 14% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 8% |
| 3 Years: | 49% |
| TTM: | -101% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 15% |
| 3 Years: | 16% |
| 1 Year: | -43% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 4% |
| 3 Years: | 8% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 9:15 am
Balance Sheet
Last Updated: December 4, 2025, 1:32 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 199 | 203 | 208 | 218 | 228 | 239 | 239 | 234 | 229 | 253 | 286 | 292 | 312 |
| Borrowings | 71 | 73 | 99 | 138 | 138 | 173 | 126 | 78 | 70 | 56 | 80 | 54 | 12 |
| Other Liabilities | 113 | 132 | 130 | 114 | 108 | 132 | 106 | 68 | 79 | 124 | 116 | 98 | 113 |
| Total Liabilities | 393 | 418 | 447 | 481 | 485 | 555 | 481 | 390 | 389 | 442 | 493 | 455 | 446 |
| Fixed Assets | 79 | 107 | 105 | 102 | 159 | 165 | 178 | 165 | 149 | 140 | 161 | 159 | 158 |
| CWIP | 6 | 1 | 25 | 50 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 0 | 10 | 11 | 6 | 5 | 14 | 14 | 13 | 10 | 16 | 18 |
| Other Assets | 307 | 309 | 317 | 320 | 316 | 383 | 297 | 211 | 225 | 290 | 322 | 280 | 270 |
| Total Assets | 393 | 418 | 447 | 481 | 485 | 555 | 481 | 390 | 389 | 442 | 493 | 455 | 446 |
Below is a detailed analysis of the balance sheet data for Kokuyo Camlin Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 312.00 Cr.. The value appears strong and on an upward trend. It has increased from 292.00 Cr. (Mar 2025) to 312.00 Cr., marking an increase of 20.00 Cr..
- For Borrowings, as of Sep 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 54.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 42.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 113.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 98.00 Cr. (Mar 2025) to 113.00 Cr., marking an increase of 15.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 446.00 Cr.. The value appears to be improving (decreasing). It has decreased from 455.00 Cr. (Mar 2025) to 446.00 Cr., marking a decrease of 9.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 158.00 Cr.. The value appears to be declining and may need further review. It has decreased from 159.00 Cr. (Mar 2025) to 158.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 270.00 Cr.. The value appears to be declining and may need further review. It has decreased from 280.00 Cr. (Mar 2025) to 270.00 Cr., marking a decrease of 10.00 Cr..
- For Total Assets, as of Sep 2025, the value is 446.00 Cr.. The value appears to be declining and may need further review. It has decreased from 455.00 Cr. (Mar 2025) to 446.00 Cr., marking a decrease of 9.00 Cr..
Notably, the Reserves (312.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -68.00 | -56.00 | -74.00 | -114.00 | -99.00 | -122.00 | -89.00 | -69.00 | -53.00 | -2.00 | -3.00 | -20.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55 | 52 | 54 | 62 | 63 | 62 | 43 | 46 | 43 | 35 | 37 | 36 |
| Inventory Days | 130 | 131 | 119 | 129 | 152 | 178 | 176 | 196 | 148 | 119 | 141 | 112 |
| Days Payable | 105 | 106 | 95 | 73 | 71 | 80 | 68 | 59 | 56 | 55 | 49 | 39 |
| Cash Conversion Cycle | 80 | 76 | 78 | 118 | 145 | 161 | 152 | 184 | 136 | 99 | 129 | 109 |
| Working Capital Days | 24 | 22 | 24 | 16 | 31 | 40 | 47 | 63 | 52 | 43 | 56 | 58 |
| ROCE % | 0% | 5% | 6% | 4% | 7% | 9% | 5% | -3% | -0% | 12% | 17% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 1.52 | 0.98 | 0.15 | 0.52 | 0.50 |
| Diluted EPS (Rs.) | 1.52 | 0.98 | 0.15 | 0.52 | 0.50 |
| Cash EPS (Rs.) | 3.30 | 2.62 | 1.35 | 1.71 | 1.58 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 24.81 | 23.76 | 22.72 | 21.81 | 21.29 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 24.81 | 23.76 | 22.72 | 21.81 | 21.29 |
| Revenue From Operations / Share (Rs.) | 68.67 | 62.76 | 62.77 | 61.23 | 54.22 |
| PBDIT / Share (Rs.) | 5.20 | 4.09 | 2.60 | 2.98 | 2.49 |
| PBIT / Share (Rs.) | 3.41 | 2.44 | 1.40 | 1.80 | 1.40 |
| PBT / Share (Rs.) | 2.27 | 1.48 | 0.22 | 0.72 | 0.42 |
| Net Profit / Share (Rs.) | 1.52 | 0.97 | 0.14 | 0.52 | 0.49 |
| NP After MI And SOA / Share (Rs.) | 1.52 | 0.97 | 0.15 | 0.52 | 0.50 |
| PBDIT Margin (%) | 7.56 | 6.51 | 4.14 | 4.86 | 4.60 |
| PBIT Margin (%) | 4.97 | 3.89 | 2.22 | 2.93 | 2.58 |
| PBT Margin (%) | 3.30 | 2.36 | 0.35 | 1.19 | 0.78 |
| Net Profit Margin (%) | 2.20 | 1.55 | 0.23 | 0.85 | 0.90 |
| NP After MI And SOA Margin (%) | 2.20 | 1.55 | 0.24 | 0.85 | 0.92 |
| Return on Networth / Equity (%) | 6.10 | 4.11 | 0.66 | 2.39 | 2.35 |
| Return on Capital Employeed (%) | 12.00 | 9.63 | 5.66 | 6.95 | 5.94 |
| Return On Assets (%) | 2.74 | 2.02 | 0.31 | 1.16 | 1.20 |
| Long Term Debt / Equity (X) | 0.10 | 0.04 | 0.06 | 0.11 | 0.04 |
| Total Debt / Equity (X) | 0.67 | 0.55 | 0.56 | 0.43 | 0.32 |
| Asset Turnover Ratio (%) | 1.32 | 1.30 | 1.36 | 1.42 | 1.34 |
| Current Ratio (X) | 1.32 | 1.25 | 1.18 | 1.57 | 1.59 |
| Quick Ratio (X) | 0.57 | 0.56 | 0.57 | 0.90 | 0.90 |
| Inventory Turnover Ratio (X) | 1.47 | 1.58 | 1.88 | 1.91 | 1.97 |
| Interest Coverage Ratio (X) | 4.53 | 4.27 | 2.22 | 2.79 | 2.56 |
| Interest Coverage Ratio (Post Tax) (X) | 2.32 | 2.02 | 1.13 | 1.49 | 1.50 |
| Enterprise Value (Cr.) | 1125.92 | 1289.55 | 1011.53 | 855.59 | 732.38 |
| EV / Net Operating Revenue (X) | 1.63 | 2.05 | 1.61 | 1.39 | 1.35 |
| EV / EBITDA (X) | 21.61 | 31.45 | 38.79 | 28.61 | 29.27 |
| MarketCap / Net Operating Revenue (X) | 1.41 | 1.84 | 1.43 | 1.35 | 1.36 |
| Price / BV (X) | 3.89 | 4.87 | 3.94 | 3.79 | 3.46 |
| Price / Net Operating Revenue (X) | 1.41 | 1.84 | 1.43 | 1.35 | 1.36 |
| EarningsYield | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 |
After reviewing the key financial ratios for Kokuyo Camlin Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 19, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 18) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 5. It has increased from 0.98 (Mar 18) to 1.52, marking an increase of 0.54.
- For Diluted EPS (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 5. It has increased from 0.98 (Mar 18) to 1.52, marking an increase of 0.54.
- For Cash EPS (Rs.), as of Mar 19, the value is 3.30. This value is within the healthy range. It has increased from 2.62 (Mar 18) to 3.30, marking an increase of 0.68.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 24.81. It has increased from 23.76 (Mar 18) to 24.81, marking an increase of 1.05.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 24.81. It has increased from 23.76 (Mar 18) to 24.81, marking an increase of 1.05.
- For Revenue From Operations / Share (Rs.), as of Mar 19, the value is 68.67. It has increased from 62.76 (Mar 18) to 68.67, marking an increase of 5.91.
- For PBDIT / Share (Rs.), as of Mar 19, the value is 5.20. This value is within the healthy range. It has increased from 4.09 (Mar 18) to 5.20, marking an increase of 1.11.
- For PBIT / Share (Rs.), as of Mar 19, the value is 3.41. This value is within the healthy range. It has increased from 2.44 (Mar 18) to 3.41, marking an increase of 0.97.
- For PBT / Share (Rs.), as of Mar 19, the value is 2.27. This value is within the healthy range. It has increased from 1.48 (Mar 18) to 2.27, marking an increase of 0.79.
- For Net Profit / Share (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 2. It has increased from 0.97 (Mar 18) to 1.52, marking an increase of 0.55.
- For NP After MI And SOA / Share (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 2. It has increased from 0.97 (Mar 18) to 1.52, marking an increase of 0.55.
- For PBDIT Margin (%), as of Mar 19, the value is 7.56. This value is below the healthy minimum of 10. It has increased from 6.51 (Mar 18) to 7.56, marking an increase of 1.05.
- For PBIT Margin (%), as of Mar 19, the value is 4.97. This value is below the healthy minimum of 10. It has increased from 3.89 (Mar 18) to 4.97, marking an increase of 1.08.
- For PBT Margin (%), as of Mar 19, the value is 3.30. This value is below the healthy minimum of 10. It has increased from 2.36 (Mar 18) to 3.30, marking an increase of 0.94.
- For Net Profit Margin (%), as of Mar 19, the value is 2.20. This value is below the healthy minimum of 5. It has increased from 1.55 (Mar 18) to 2.20, marking an increase of 0.65.
- For NP After MI And SOA Margin (%), as of Mar 19, the value is 2.20. This value is below the healthy minimum of 8. It has increased from 1.55 (Mar 18) to 2.20, marking an increase of 0.65.
- For Return on Networth / Equity (%), as of Mar 19, the value is 6.10. This value is below the healthy minimum of 15. It has increased from 4.11 (Mar 18) to 6.10, marking an increase of 1.99.
- For Return on Capital Employeed (%), as of Mar 19, the value is 12.00. This value is within the healthy range. It has increased from 9.63 (Mar 18) to 12.00, marking an increase of 2.37.
- For Return On Assets (%), as of Mar 19, the value is 2.74. This value is below the healthy minimum of 5. It has increased from 2.02 (Mar 18) to 2.74, marking an increase of 0.72.
- For Long Term Debt / Equity (X), as of Mar 19, the value is 0.10. This value is below the healthy minimum of 0.2. It has increased from 0.04 (Mar 18) to 0.10, marking an increase of 0.06.
- For Total Debt / Equity (X), as of Mar 19, the value is 0.67. This value is within the healthy range. It has increased from 0.55 (Mar 18) to 0.67, marking an increase of 0.12.
- For Asset Turnover Ratio (%), as of Mar 19, the value is 1.32. It has increased from 1.30 (Mar 18) to 1.32, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 19, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.25 (Mar 18) to 1.32, marking an increase of 0.07.
- For Quick Ratio (X), as of Mar 19, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 18) to 0.57, marking an increase of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 19, the value is 1.47. This value is below the healthy minimum of 4. It has decreased from 1.58 (Mar 18) to 1.47, marking a decrease of 0.11.
- For Interest Coverage Ratio (X), as of Mar 19, the value is 4.53. This value is within the healthy range. It has increased from 4.27 (Mar 18) to 4.53, marking an increase of 0.26.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 19, the value is 2.32. This value is below the healthy minimum of 3. It has increased from 2.02 (Mar 18) to 2.32, marking an increase of 0.30.
- For Enterprise Value (Cr.), as of Mar 19, the value is 1,125.92. It has decreased from 1,289.55 (Mar 18) to 1,125.92, marking a decrease of 163.63.
- For EV / Net Operating Revenue (X), as of Mar 19, the value is 1.63. This value is within the healthy range. It has decreased from 2.05 (Mar 18) to 1.63, marking a decrease of 0.42.
- For EV / EBITDA (X), as of Mar 19, the value is 21.61. This value exceeds the healthy maximum of 15. It has decreased from 31.45 (Mar 18) to 21.61, marking a decrease of 9.84.
- For MarketCap / Net Operating Revenue (X), as of Mar 19, the value is 1.41. This value is within the healthy range. It has decreased from 1.84 (Mar 18) to 1.41, marking a decrease of 0.43.
- For Price / BV (X), as of Mar 19, the value is 3.89. This value exceeds the healthy maximum of 3. It has decreased from 4.87 (Mar 18) to 3.89, marking a decrease of 0.98.
- For Price / Net Operating Revenue (X), as of Mar 19, the value is 1.41. This value is within the healthy range. It has decreased from 1.84 (Mar 18) to 1.41, marking a decrease of 0.43.
- For EarningsYield, as of Mar 19, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 18) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kokuyo Camlin Ltd:
- Net Profit Margin: 2.2%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12% (Industry Average ROCE: 9.42%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.1% (Industry Average ROE: 9.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.32
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 50.8 (Industry average Stock P/E: 85.18)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.67
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.2%
Fundamental Analysis of Kokuyo Camlin Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Printing/Publishing/Stationery | Hilton House, 48/2, Central Road, Mumbai Maharashtra 400093 | investorrelations@kokuyocamlin.com http://www.kokuyocamlin.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dilip Dandekar | Chairman & Executive Director |
| Mr. Koji Higashiguchi | Non Executive Director |
| Mr. Shriram Dandekar | Vice Chairman & Exe.Director |
| Mr. Nobuchika Doi | Non Executive Director |
| Mr. Yasuyuki Kanebako | Independent Director |
| Mr. Shishir Desai | Independent Director |
| Mr. Sriram Venkataraman | Independent Director |
| Ms. Nandini Chopra | Independent Director |
Kokuyo Camlin Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹151.95 |
| Previous Day | ₹156.85 |
FAQ
What is the intrinsic value of Kokuyo Camlin Ltd?
Kokuyo Camlin Ltd's intrinsic value (as of 06 December 2025) is 25.95 which is 71.79% lower the current market price of 92.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 923 Cr. market cap, FY2025-2026 high/low of 145/91.0, reserves of ₹312 Cr, and liabilities of 446 Cr.
What is the Market Cap of Kokuyo Camlin Ltd?
The Market Cap of Kokuyo Camlin Ltd is 923 Cr..
What is the current Stock Price of Kokuyo Camlin Ltd as on 06 December 2025?
The current stock price of Kokuyo Camlin Ltd as on 06 December 2025 is 92.0.
What is the High / Low of Kokuyo Camlin Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kokuyo Camlin Ltd stocks is 145/91.0.
What is the Stock P/E of Kokuyo Camlin Ltd?
The Stock P/E of Kokuyo Camlin Ltd is 50.8.
What is the Book Value of Kokuyo Camlin Ltd?
The Book Value of Kokuyo Camlin Ltd is 32.1.
What is the Dividend Yield of Kokuyo Camlin Ltd?
The Dividend Yield of Kokuyo Camlin Ltd is 0.00 %.
What is the ROCE of Kokuyo Camlin Ltd?
The ROCE of Kokuyo Camlin Ltd is 3.65 %.
What is the ROE of Kokuyo Camlin Ltd?
The ROE of Kokuyo Camlin Ltd is 1.95 %.
What is the Face Value of Kokuyo Camlin Ltd?
The Face Value of Kokuyo Camlin Ltd is 1.00.